Cargando…
Does CYP2E1 RsaI/PstI polymorphism confer head and neck carcinoma susceptibility?: A meta-analysis based on 43 studies
BACKGROUND: Previous reports showed that CYP2E1 RsaI/PstI polymorphism may be a risk factor for cancers. Published meta-analyses in 2010 and 2011, respectively, on the relationship of CYP2E1 RsaI/PstI polymorphisms with the susceptibility to head and neck carcinoma (HNC) have generated inconsistent...
Autores principales: | Zhuo, Xianlu, Song, Jue, Liao, Jian, Zhou, Wei, Ye, Huiping, Li, Qi, Xiang, Zhaolan, Zhang, Xueyuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5089101/ https://www.ncbi.nlm.nih.gov/pubmed/27787372 http://dx.doi.org/10.1097/MD.0000000000005156 |
Ejemplares similares
-
CYP2E1 RsaI/PstI Polymorphism and Gastric Cancer Susceptibility: Meta-Analyses Based on 24 Case-Control Studies
por: Zhuo, Wenlei, et al.
Publicado: (2012) -
Functional PstI/RsaI Polymorphism in CYP2E1 Is Associated with the Development, Progression and Poor Outcome of Gastric Cancer
por: Feng, Jin, et al.
Publicado: (2012) -
The PstI/RsaI and DraI polymorphisms of CYP2E1 and head and neck cancer risk: a meta-analysis based on 21 case-control studies
por: Tang, Kefu, et al.
Publicado: (2010) -
Cytochrome P450 2E1 RsaI/PstI polymorphism and risk of esophageal cancer: A meta-analysis of 17 case-control studies
por: LENG, WEI-DONG, et al.
Publicado: (2012) -
Is MDM2 SNP309 Variation a Risk Factor for Head and Neck Carcinoma?: An Updated Meta-Analysis Based on 11,552 Individuals
por: Zhuo, Xianlu, et al.
Publicado: (2016)